View:
Download DOC
Download PDF
Download XLS
SC 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13G

UNDER THE SECURITIES AND EXCHANGE ACT OF 1934

(Amendment No.     )

 

 

Collegium Pharmaceutical, Inc.

(Name of Issuer)

Common Stock, par value $.001 per share

(Title of Class of Securities)

19459J104

(CUSIP Number)

December 31, 2015

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

CUSIP No.  19459J104   SCHEDULE 13G   Page 1 of 17 Pages

 

  1.   

NAMES OF REPORTING PERSONS

 

Boston Millennia Associates II Partnership

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨        (b)  x

 

  3.  

SEC USE ONLY

 

    

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware general partnership

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

 

       5.     

SOLE VOTING POWER

 

0

      6.     

SHARED VOTING POWER

 

4,666

      7.     

SOLE DISPOSITIVE POWER

 

0

      8.     

SHARED DISPOSITIVE POWER

 

4,666

9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

4,666

10.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

    

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

Less than 0.1%

12.  

TYPE OF REPORTING PERSON

 

PN

CUSIP No.  19459J104   SCHEDULE 13G   Page 2 of 17 Pages

 

  1.   

NAMES OF REPORTING PERSONS

 

Boston Millennia Partners II Limited Partnership

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨        (b)  x

 

  3.  

SEC USE ONLY

 

    

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware limited partnership

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

 

       5.     

SOLE VOTING POWER

 

0

      6.     

SHARED VOTING POWER

 

898,445

      7.     

SOLE DISPOSITIVE POWER

 

0

      8.     

SHARED DISPOSITIVE POWER

 

898,445

9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

898,445

10.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

    

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

4.3%

12.  

TYPE OF REPORTING PERSON

 

PN

CUSIP No.  19459J104   SCHEDULE 13G   Page 3 of 17 Pages

 

  1.   

NAMES OF REPORTING PERSONS

 

Boston Millennia Partners II-A Limited Partnership

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨        (b)  x

 

  3.  

SEC USE ONLY

 

    

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware limited partnership

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

 

       5.     

SOLE VOTING POWER

 

0

      6.     

SHARED VOTING POWER

 

43,035

      7.     

SOLE DISPOSITIVE POWER

 

0

      8.     

SHARED DISPOSITIVE POWER

 

43,035

9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

43,035

10.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

    

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

0.2%

12.  

TYPE OF REPORTING PERSON

 

PN

CUSIP No.  19459J104   SCHEDULE 13G   Page 4 of 17 Pages

 

  1.   

NAMES OF REPORTING PERSONS

 

Strategic Advisors Fund Limited Partnership

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨        (b)  x

 

  3.  

SEC USE ONLY

 

    

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware limited partnership

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

 

       5.     

SOLE VOTING POWER

 

0

      6.     

SHARED VOTING POWER

 

8,077

      7.     

SOLE DISPOSITIVE POWER

 

0

      8.     

SHARED DISPOSITIVE POWER

 

8,077

9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

8,077

10.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

    

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

Less than 0.1%

12.  

TYPE OF REPORTING PERSON

 

PN

CUSIP No.  19459J104   SCHEDULE 13G   Page 5 of 17 Pages

 

  1.   

NAMES OF REPORTING PERSONS

 

Boston Millennia Partners GmbH & Co. KG

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨        (b)  x

 

  3.  

SEC USE ONLY

 

    

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

German limited partnership

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

 

       5.     

SOLE VOTING POWER

 

0

      6.     

SHARED VOTING POWER

 

127,937

      7.     

SOLE DISPOSITIVE POWER

 

0

      8.     

SHARED DISPOSITIVE POWER

 

127,937

9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

127,937

10.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

    

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

0.6%

12.  

TYPE OF REPORTING PERSON

 

PN

CUSIP No.  19459J104   SCHEDULE 13G   Page 6 of 17 Pages

 

  1.   

NAMES OF REPORTING PERSONS

 

Glen Partners II Limited Partnership

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨        (b)  x

 

  3.  

SEC USE ONLY

 

    

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware limited partnership

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

 

       5.     

SOLE VOTING POWER

 

0

      6.     

SHARED VOTING POWER

 

1,077,494

      7.     

SOLE DISPOSITIVE POWER

 

0

      8.     

SHARED DISPOSITIVE POWER

 

1,077,494

9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,077,494

10.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

    

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.2%

12.  

TYPE OF REPORTING PERSON

 

PN

CUSIP No.  19459J104   SCHEDULE 13G   Page 7 of 17 Pages

 

  1.   

NAMES OF REPORTING PERSONS

 

Boston Millennia Verwaltungs GmbH

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨        (b)  x

 

  3.  

SEC USE ONLY

 

    

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

German corporation

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

 

       5.     

SOLE VOTING POWER

 

0

      6.     

SHARED VOTING POWER

 

127,937

      7.     

SOLE DISPOSITIVE POWER

 

0

      8.     

SHARED DISPOSITIVE POWER

 

127,937

9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

127,937

10.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

    

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

0.6%

12.  

TYPE OF REPORTING PERSON

 

CO

CUSIP No.  19459J104   SCHEDULE 13G   Page 8 of 17 Pages

 

  1.   

NAMES OF REPORTING PERSONS

 

A. Dana Callow, Jr.

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨        (b)  x

 

  3.  

SEC USE ONLY

 

    

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

U.S.A

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

 

       5.     

SOLE VOTING POWER

 

0

      6.     

SHARED VOTING POWER

 

1,082,160

      7.     

SOLE DISPOSITIVE POWER

 

0

      8.     

SHARED DISPOSITIVE POWER

 

1,082,160

9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,082,160

10.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

    

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.2%

12.  

TYPE OF REPORTING PERSON

 

IN

 

CUSIP No.  19459J104   SCHEDULE 13G   Page 9 of 17 Pages

 

  1.   

NAMES OF REPORTING PERSONS

 

Robert S. Sherman

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨        (b)  x

 

  3.  

SEC USE ONLY

 

    

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

U.S.A

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

 

       5.     

SOLE VOTING POWER

 

0

      6.     

SHARED VOTING POWER

 

1,082,160

      7.     

SOLE DISPOSITIVE POWER

 

0

      8.     

SHARED DISPOSITIVE POWER

 

1,082,160

9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,082,160

10.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

    

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.2%

12.  

TYPE OF REPORTING PERSON

 

IN

CUSIP No.  19459J104   SCHEDULE 13G   Page 10 of 17 Pages

 

  1.   

NAMES OF REPORTING PERSONS

 

Martin J. Hernon

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨        (b)  x

 

  3.  

SEC USE ONLY

 

    

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

U.S.A

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

 

       5.     

SOLE VOTING POWER

 

0

      6.     

SHARED VOTING POWER

 

1,082,160

      7.     

SOLE DISPOSITIVE POWER

 

0

      8.     

SHARED DISPOSITIVE POWER

 

1,082,160

9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,082,160

10.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ¨

 

    

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.2%

12.  

TYPE OF REPORTING PERSON

 

IN

CUSIP No.  19459J104   SCHEDULE 13G   Page 11 of 17 Pages

 

ITEM 1 (a).   NAME OF ISSUER:

Collegium Pharmaceutical, Inc.

 

ITEM 1 (b).   ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:

780 Dedham Street, Suite 800

Canton, MA 02021

 

ITEM 2 (a).   NAME OF PERSON FILING:

This statement is filed by Boston Millennia Associates II Partnership (“BMAP”), a Delaware general partnership, Boston Millennia Partners II Limited Partnership (“BMP II”), a Delaware limited partnership, Boston Millennia Partners II-A Limited Partnership (“BMP II-A”), a Delaware limited partnership, Strategic Advisors Fund Limited Partnership (“SAF”), a Delaware limited partnership, Boston Millennia Partners GmbH & Co. KG (“BMP-G”), a German limited partnership, Glen Partners II Limited Partnership (“GP”), a Delaware limited partnership, Boston Millennia Verwaltungs GmbH (“BMV”), a German corporation, and A. Dana Callow, Jr., Robert S. Sherman and Martin J. Hernon (collectively, the “Partners”). BMAP, BMP II, BMP II-A, SAF, BMP-G, GP, BMV, and Messrs. Callow, Sherman, and Hernon are collectively referred to as the “Reporting Persons.”

 

ITEM 2 (b).   ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR, IF NONE, RESIDENCE:

30 Rowes Wharf

Boston, Massachusetts 02110

 

ITEM 2 (c).   CITIZENSHIP:

BMAP is a general partnership organized under the laws of Delaware.

Each of BMP II, BMP II-A, SAF, and GP is a limited partnership organized under the laws of Delaware.

BMP-G is a limited partnership organized under the laws of the Federal Republic of Germany.

BMV is a corporation organized under the laws of the Federal Republic of Germany.

Each of the Partners is a citizen of the United States.

 

ITEM 2 (d).   TITLE OF CLASS OF SECURITIES:

This Schedule 13G relates to the Common Stock, par value $0.001 (“Common Stock”), of Collegium Pharmaceutical, Inc. (the “Company”).

 

ITEM 2 (e).   CUSIP NUMBER:

19459J104

 

ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b) or (c), CHECK WHETHER THE PERSON FILING IS A:

 

 

¨

      (a )    Broker or dealer registered under section 15 of the Exchange Act.
 

¨

      (b )    Bank as defined in section 3(a)(6) of the Exchange Act.
 

¨

      (c )    Insurance company as defined in section 3(a)(l9) of the Exchange Act.
 

¨

      (d )    Investment company registered under section 8 of the Investment Company Act.
 

¨

      (e )    An investment adviser in accordance with Rule 13d-l(b)(l)(ii)(E);
 

¨

      (f )    An employee benefit plan or endowment fund in accordance with Rule 13d-l(b)(l)(ii)(F);
 

¨

      (g )    A parent holding company or control person in accordance with Rule 13d-l(b)(l)(ii)(G);
 

¨

      (h )    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act;
 

¨

      (i )    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act;
 

¨

      (j )    Group, in accordance with Rule 13d-l (b)(1)(ii)(J).

Not applicable.

CUSIP No.  19459J104   SCHEDULE 13G   Page 12 of 17 Pages

 

ITEM 4. OWNERSHIP.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

  (a) Amount beneficially owned:

As of December 31, 2015, each of the following is the beneficial owner of the number of shares of Common Stock indicated:

 

     Shares Beneficially Owned  

BMAP

      4,666 shares   

BMP II

      898,445 shares   

BMP II-A

      43,035 shares i 

SAF

      8,077 shares   

BMP-G

      127,937 shares   

GP

      1,077,494 shares   

BMV

      127,937 shares   

Mr. Callow

      1,082,160 shares   

Mr. Sherman

      1,082,160 shares   

Mr. Hernon

      1,082,160 shares   

 

  (b) Percent of Class:

 

BMAP

      Less than 0.1 % 

BMP II

      4.3 % 

BMP II-A

      0.2 % 

SAF

      Less than 0.1 % 

BMP-G

      0.6 % 

GP

      5.2 % 

BMV

      0.6 % 

Mr. Callow

      5.2 % 

Mr. Sherman

      5.2 % 

Mr. Hernon

      5.2 % 

GP, by virtue of its status as the sole general partner of BMP II, BMP II-A and SAF, and special limited partner of BMP-G, may be deemed to be the beneficial owner of 1,077,494 shares, representing beneficial ownership of 5.2%. BMV, by virtue of its status as the sole general partner of BMP-G, may be deemed to be the beneficial owner of 127,937 shares, representing beneficial ownership of 0.6%. By virtue of their status as the general partners of GP, managing directors of BMV-G, and managing general partners of BMA, each of Messrs. Callow, Sherman, and Hernon may be deemed each to be the beneficial owner of 1,082,160 shares, representing in the case of each Partner beneficial ownership of 5.2%. The foregoing percentages are based on the 20,688,914 shares of Common Stock indicated by the Company to be outstanding as of October 31, 2015.

 

  (c) Number of shares as to which such person has:

 

     Number of Shares:  

Reporting Person

    (i)      (ii)      (iii)      (iv)  

BMAP

      0         4,666         0         4,666   

BMP II

      0         898,445         0         898,445   

BMP II-A

      0         43,035         0         43,035   

SAF

      0         8,077         0         8,0777   

BMP-G

      0         127,937         0         127,937   

GP

      0         1,077,494         0         1,077,494   

BMV

      0         127,937         0         127,937   

Mr. Callow

      0         1,082,160         0         1,082,160   

Mr. Sherman

      0         1,082,160         0         1,082,160   

Mr. Hernon

      0         1,082,160         0         1,082,160   

 

  (i) Sole power to vote or to direct the vote

CUSIP No.  19459J104   SCHEDULE 13G   Page 13 of 17 Pages

 

  (ii) Shared power to vote or to direct the vote

 

  (iii) Sole power to dispose or direct the disposition of

 

  (iv) Shared power to dispose or direct the disposition of

 

ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF CLASS.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ]

 

ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

Not applicable.

 

ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON.

Not applicable.

 

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

Not applicable

 

ITEM 9. NOTICE OF DISSOLUTION OF GROUP.

Not applicable.

 

ITEM 10. CERTIFICATIONS.

Not applicable.

Attached as Exhibit 1 hereto is a Joint Filing Agreement executed by each of the filing persons pursuant to Rule 13d-l(k)(1) of the Securities Exchange Act of 1934, as amended.

CUSIP No.  19459J104   SCHEDULE 13G   Page 14 of 17 Pages

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

January 22, 2016

 

Boston Millennia Associates II Partnership
By:   /s/ Martin J. Hernon
  Martin J. Hernon
  Managing General Partner
Boston Millennia Partners II Limited Partnership
By:   Glen Partners II Limited Partnership
  Its General Partner
By:   /s/ Martin J. Hernon
  Martin J. Hernon
  General Partner
Boston Millennia Partners II-A Limited Partnership
By:   Glen Partners II Limited Partnership
  Its General Partner
By:   /s/ Martin J. Hernon
  Martin J. Hernon
  General Partner
Strategic Advisors Fund Limited Partnership
By:   Glen Partners II Limited Partnership
  Its General Partner
By:   /s/ Martin J. Hernon
  Martin J. Hernon
  General Partner

CUSIP No.  19459J104   SCHEDULE 13G   Page 15 of 17 Pages

 

Boston Millennia Partners GmbH & Co. KG
By:   Boston Millennia Verwaltungs GmbH
  Its General Partner
By:   /s/ Martin J. Hernon
  Martin J. Hernon
  Managing Director
Glen Partners II Limited Partnership
By:   /s/ Martin J. Hernon
  Martin J. Hernon
  General Partner
Boston Millennia Verwaltungs GmbH
By:   /s/ Martin J. Hernon
  Martin J. Hernon
  Managing Director
/s/ A. Dana Callow, Jr.
A. Dana Callow, Jr.
/s/ Robert S. Sherman
Robert S. Sherman
/s/ Martin J. Hernon
Martin J. Hernon

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations. (See 18 U.S.C. 1001)

CUSIP No.  19459J104   SCHEDULE 13G   Page 16 of 17 Pages

 

Exhibit 1

Joint Filing Agreement

In accordance with Rule 13d-l(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned agree that only one statement containing the information required by Schedule 13G need be filed by each of the undersigned with respect to the ownership by each of the undersigned of shares of common stock of Collegium Pharmaceutical, Inc. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original.

January 22, 2016

 

Boston Millennia Associates II Partnership
By:   /s/ Martin J. Hernon
  Martin J. Hernon
  Managing General Partner
Boston Millennia Partners II Limited Partnership
By:  

Glen Partners II Limited Partnership

Its General Partner

By:   /s/ Martin J. Hernon
  Martin J. Hernon
  General Partner
Boston Millennia Partners II-A Limited Partnership
By:  

Glen Partners II Limited Partnership

Its General Partner

By:   /s/ Martin J. Hernon
  Martin J. Hernon
  General Partner
Strategic Advisors Fund Limited Partnership
By:  

Glen Partners II Limited Partnership

Its General Partner

By:   /s/ Martin J. Hernon
  Martin J. Hernon
  General Partner

CUSIP No.  19459J104   SCHEDULE 13G   Page 17 of 17 Pages

 

Boston Millennia Partners GmbH & Co. KG
By:  

Boston Millennia Verwaltungs GmbH

Its General Partner

By:   /s/ Martin J. Hernon
  Martin J. Hernon
  Managing Director
Glen Partners II Limited Partnership
By:   /s/ Martin J. Hernon
  Martin J. Hernon
  General Partner
Boston Millennia Verwaltungs GmbH
By:   /s/ Martin J. Hernon
  Martin J. Hernon
  Managing Director
/s/ A. Dana Callow, Jr.
A. Dana Callow, Jr.
/s/ Robert S. Sherman
Robert S. Sherman
/s/ Martin J. Hernon
Martin J. Hernon